We also tested whether the four immune checkpoints (PD-L1, CD276, CTLA4, LAG3), which differ in tumor and normal tissues, differed in two clusters, showing that CD276 expression was higher in cluster2 than in cluster1, while CTLA4 expression was lower than in cluster1. This evidence concerns the gene CD276 and neoplasm.